Study to Evaluate the Safety and Pharmacokinetics of CKD-331

Clinical trial NCT05335044 · COMPLETED

Trial details

NCT number: NCT05335044
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension and Dyslipidemia

Start date: 2022-05-31
Primary completion: 2022-06-23
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.